|
CN1961003B
(zh)
*
|
2004-03-31 |
2013-03-27 |
健泰科生物技术公司 |
人源化抗TGF-β抗体
|
|
JP2009521496A
(ja)
*
|
2005-12-23 |
2009-06-04 |
イーライ リリー アンド カンパニー |
ＴＧＦ−β結合組成物
|
|
US8350006B2
(en)
*
|
2008-10-24 |
2013-01-08 |
Mead Johnson Nutrition Company |
Methods for determining the bioactivity of TGF-β in a composition
|
|
EP2382321A4
(en)
*
|
2009-01-08 |
2012-12-19 |
Bio Rad Laboratories |
METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY OF NUCLEIC ACID AMPLIFICATION REACTIONS
|
|
US20120294868A1
(en)
*
|
2009-04-24 |
2012-11-22 |
Edwards James R |
Anti-tgf-beta induction of bone cell function and bone growth
|
|
SG195253A1
(en)
|
2011-06-03 |
2013-12-30 |
Xoma Technology Ltd |
Antibodies specific for tgf-beta
|
|
US10259626B2
(en)
|
2012-03-08 |
2019-04-16 |
Selig Sealing Products, Inc. |
Container sealing member with protected security component and removal tab
|
|
WO2013134365A1
(en)
|
2012-03-08 |
2013-09-12 |
Ludwig Institute For Cancer Research Ltd |
TGF-β1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
|
|
HUE046702T2
(hu)
*
|
2013-03-20 |
2020-03-30 |
Genzyme Corp |
Eljárások üvegcsontbetegség kezelésére
|
|
JPWO2016024628A1
(ja)
*
|
2014-08-14 |
2017-09-21 |
学校法人東京医科大学 |
樹状細胞の抗癌免疫賦活能の促進方法およびその用途
|
|
EP3244926B8
(en)
|
2015-01-14 |
2024-08-21 |
The Brigham and Women's Hospital, Inc. |
Treatment of cancer with anti-lap monoclonal antibodies
|
|
TWI726870B
(zh)
|
2015-03-04 |
2021-05-11 |
美商健臻公司 |
具有高親和性、結合性及專一性之結合轉形生長因子-β１的ｓｃＦｖ-Ｆｃ二聚體
|
|
TWI733661B
(zh)
|
2015-03-04 |
2021-07-21 |
美商健臻公司 |
以高親合性、結合性及特異性結合轉化生長因子－β１的經修飾ＩｇＧ抗體
|
|
EP3770171A1
(en)
|
2015-04-03 |
2021-01-27 |
XOMA Technology Ltd. |
Treatment of cancer using inhibitors of tgf-beta and pd-1
|
|
US10723793B2
(en)
|
2015-06-12 |
2020-07-28 |
Ludwig Institute For Cancer Research, Ltd. |
TGF-β3 specific antibodies and methods and uses thereof
|
|
WO2017201036A1
(en)
|
2016-05-17 |
2017-11-23 |
Genentech, Inc. |
Stromal gene signatures for diagnosis and use in immunotherapy
|
|
GB201610044D0
(en)
|
2016-06-08 |
2016-07-20 |
Ucb Biopharma Sprl |
Antibodies
|
|
CN109071656B
(zh)
|
2017-01-05 |
2021-05-18 |
璟尚生物制药公司 |
检查点调节物拮抗剂
|
|
TWI788321B
(zh)
*
|
2017-01-20 |
2023-01-01 |
美商健臻公司 |
骨靶向抗體
|
|
ES2984919T3
(es)
|
2017-11-06 |
2024-10-31 |
Hoffmann La Roche |
Procedimientos diagnósticos y terapéuticos para el cáncer
|
|
CN112739717B
(zh)
|
2018-06-29 |
2025-02-11 |
璟尚生物制药公司 |
三特异性拮抗剂
|
|
WO2020095113A1
(en)
|
2018-11-05 |
2020-05-14 |
Ludwig Institute For Cancer Research Ltd |
Humanized and variant tgf-beta1 specific antibodies and methods and uses thereof
|
|
CN113613726B
(zh)
|
2018-11-05 |
2025-07-15 |
路德维格癌症研究所有限公司 |
人源化和变体TGF-β3特异性抗体及其方法和用途
|
|
US10851157B2
(en)
|
2019-07-01 |
2020-12-01 |
Gensun Biopharma, Inc. |
Antagonists targeting the TGF-β pathway
|
|
CA3152371A1
(en)
|
2019-08-01 |
2021-02-04 |
Vaccinex, Inc. |
Combined inhibition of semaphorin-4d and tgf.beta. and compositions therefor
|
|
US11801304B2
(en)
|
2020-02-19 |
2023-10-31 |
Nammi Therapeutics, Inc. |
Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof
|
|
CN113563473A
(zh)
|
2020-04-29 |
2021-10-29 |
三生国健药业（上海）股份有限公司 |
四价双特异性抗体、其制备方法和用途
|
|
US20220119513A1
(en)
*
|
2020-06-08 |
2022-04-21 |
Zoetis Services Llc |
Anti-tgfb antibodies and therapeutic uses thereof
|
|
US20240002479A1
(en)
*
|
2020-11-23 |
2024-01-04 |
The Regents Of The University Of Michigan |
Single-chain antibody against flavivirus ns1 protein
|
|
WO2022115611A1
(en)
|
2020-11-25 |
2022-06-02 |
Catamaran Bio, Inc. |
Cellular therapeutics engineered with signal modulators and methods of use thereof
|
|
CN112940119B
(zh)
*
|
2021-04-26 |
2022-05-20 |
北京芳渟阳生生物科技有限公司 |
一种单克隆抗体及其与间充质干细胞外泌体的联合应用
|
|
CN115707716A
(zh)
*
|
2021-08-18 |
2023-02-21 |
丹生医药技术(上海)有限公司 |
一种TGF-β/VEGF双功能抗体融合蛋白
|
|
WO2023080900A1
(en)
|
2021-11-05 |
2023-05-11 |
Genentech, Inc. |
Methods and compositions for classifying and treating kidney cancer
|
|
US20250282874A1
(en)
|
2022-05-17 |
2025-09-11 |
Suzhou Transcenta Therapeutics Co., Ltd. |
Bifunctional protein, and preparation thereof and use thereof
|
|
WO2024077166A1
(en)
|
2022-10-05 |
2024-04-11 |
Genentech, Inc. |
Methods and compositions for classifying and treating lung cancer
|
|
WO2024077095A1
(en)
|
2022-10-05 |
2024-04-11 |
Genentech, Inc. |
Methods and compositions for classifying and treating bladder cancer
|
|
WO2024149237A1
(zh)
*
|
2023-01-09 |
2024-07-18 |
北京拓界生物医药科技有限公司 |
TGFβ1结合分子、GARP-TGFβ1结合分子及其医药用途
|